Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for CytRx Corporation (CYTR)

« Back to company index

CYTR Chatter Timeline

Stock Ticker for CYTR

Most Active Tweeters for CYTR

UserTweets
@ledgerzette 2
@BACScoreChanges 1
@greenpenny2016 1
@EnterpriseLeade 1
@OlympiaReport 1

Recent Tweets for CYTR

ledgerzette @ledgerzette
Head to Head Analysis: Fate Therapeutics $FATE and CytRx $CYTR https://t.co/yEcDU3IaoD
July 17th 2018, 7:07am
dakotafinancial @dakotafinancial
Head to Head Analysis: Fate Therapeutics $FATE and CytRx $CYTR https://t.co/KYEf6834A4
July 17th 2018, 7:07am
StockNewsNow @StockNewsNow
$CYTR CytRx Corporation to Present at the Singular Research Summer Solstice 2018 Conference https://t.co/JVbZz2izuo
July 16th 2018, 12:07pm
hotpennyalerts @hotpennyalerts
$CYTR to present a corporate overview at upcoming Conference https://t.co/Q8LbrnBX4W
July 16th 2018, 10:07am
greenpenny2016 @greenpenny2016
$CYTR - CytRx Corporation to Present at the Singular Research Summer Solstice 2018 Conference https://t.co/Qaz1xa3PgR
July 16th 2018, 9:07am
WeekHerald @WeekHerald
Head-To-Head Comparison: Fate Therapeutics $FATE versus CytRx $CYTR https://t.co/mnoyXRpmHc
July 15th 2018, 2:07pm
MareaInformativ @MareaInformativ
Head-To-Head Comparison: Fate Therapeutics $FATE versus CytRx $CYTR https://t.co/fJsDS8K9xp
July 15th 2018, 6:07am
OlympiaReport @OlympiaReport
Head-To-Head Comparison: Fate Therapeutics $FATE versus CytRx $CYTR https://t.co/Id0gBjGWwc
July 15th 2018, 5:07am
wolfandblondie @wolfandblondie
RT @TomMathies: @adamfeuerstein $CYTR shareholder proposal for August 9 stockholders meeting: Amend charter to terminate CEO upon felony co…
July 10th 2018, 3:07pm
TomMathies @TomMathies
@adamfeuerstein $CYTR shareholder proposal for August 9 stockholders meeting: Amend charter to terminate CEO upon f… https://t.co/EHYfG1e0Fk
July 10th 2018, 10:07am
dailypoliticaln @dailypoliticaln
CytRx Co. $CYTR Expected to Post Earnings of -$0.18 Per Share https://t.co/gJDhTsogfH
July 8th 2018, 5:07pm
BACScoreChanges @BACScoreChanges
#CytRx $CYTR BidaskScore is Increased to Held
July 8th 2018, 3:07pm
ZolmaxNews @ZolmaxNews
CytRx $CYTR Cut to “Hold” at Zacks Investment Research https://t.co/KWcvoHwo3W
July 7th 2018, 9:07am
ledgerzette @ledgerzette
Brokerages Expect CytRx Co. $CYTR to Post -$0.18 Earnings Per Share https://t.co/FDlX8vXwPC
July 6th 2018, 1:07pm
EnterpriseLeade @EnterpriseLeade
CytRx $CYTR Stock Rating Lowered by Zacks Investment Research https://t.co/TIRbiQOXI9
July 6th 2018, 8:07am
giovannimyles @giovannimyles
$CYTR looks interesting here. Set its 252 day low a few days ago and is reversing trend. Its breaking above the fal… https://t.co/nQJbIHsUDr
July 5th 2018, 8:07pm
confcalltran @confcalltran
CytRx Corporation releases salary data. CEO sees compensation fall -18%25 https://t.co/lGkHkr2dTz $CYTR
July 5th 2018, 6:07am
Allstocknews @Allstocknews
$CYTR New Form DEF 14A for CytRx Corporation From our Stock News Alerts App
July 5th 2018, 6:07am
dakotafinancial @dakotafinancial
Zacks Investment Research Lowers CytRx $CYTR to Hold https://t.co/M0u0YgBdDE
July 4th 2018, 6:07am
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Expect CytRx Co. $CYTR to Announce -$0.18 Earnings Per Share https://t.co/780Mv2o4RS
July 4th 2018, 5:07am
dakotafinancial @dakotafinancial
-$0.18 Earnings Per Share Expected for CytRx Co. $CYTR This Quarter https://t.co/Rz51C8ylaL
July 1st 2018, 10:07pm
TickerReport @TickerReport
Analyzing CytRx $CYTR and BioCryst Pharmaceuticals $BCRX https://t.co/tUarJe15H1
July 1st 2018, 3:07am
1stOncology @1stOncology
#CytRx Highlights Aldoxorubicin Included in New #NantCell #TripleNegativeBreastCancer #TNBC Clinical Trial $CYTR https://t.co/4KfQ63GLie
June 29th 2018, 12:06pm
StockNewsNow @StockNewsNow
$CYTR CytRx Corporation Highlights Aldoxorubicin Included in New NantCell Inc. Triple Negative Breast Cancer Clinic… https://t.co/dhKLrjch2y
June 28th 2018, 11:06am
svedding @svedding
$CYTR CytRx Corporation Highlights Aldoxorubicin Included in New NantCell Inc. Triple Negative Breast C... https://t.co/Le3KgQHyjB
June 28th 2018, 9:06am
BoardCentral @BoardCentral
$CYTR "Duhhh, because CYTR''s pps has maybe bottomed out" on ADFN InvestorsHub message boards: https://t.co/9yhqw8JxqF
June 27th 2018, 11:06pm
TomMathies @TomMathies
@adamfeuerstein $CYTR 1.20, down 39% in 7 months after PR announced "investigation to determine the extent of short… https://t.co/broTQNFcPp
June 26th 2018, 12:06pm
hotpennyalerts @hotpennyalerts
$CYTR added to the Russell Microcap Index https://t.co/x4OYDYXn1S
June 25th 2018, 9:06am
Allstocknews @Allstocknews
$CYTR New Form 8-K for CytRx Corporation From our Stock News Alerts App
June 22nd 2018, 12:06pm
WatchlistN @WatchlistN
CytRx Co. $CYTR Expected to Post Earnings of -$0.18 Per Share https://t.co/OZtBK2i5mN
June 21st 2018, 8:06pm
WeekHerald @WeekHerald
Brokerages Expect CytRx Co. $CYTR to Post -$0.18 Earnings Per Share https://t.co/TOwuZvpfHl
June 21st 2018, 8:06pm
StockNewsNow @StockNewsNow
$CYTR CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology https://t.co/9yE0QPO6F3
June 21st 2018, 12:06pm
savagetrading @savagetrading
https://t.co/Qqx4MCLTw3 CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology $CYTR
June 21st 2018, 9:06am
greenpenny2016 @greenpenny2016
$CYTR - CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology https://t.co/j82POCPyl0
June 21st 2018, 9:06am
Analyze4dollars @Analyze4dollars
$CYTR remains a plausible gap fill candidate on a mid term basis. Accumulation on a strong bottom never hurts. Explosive potential
June 20th 2018, 6:06pm
BACScoreChanges @BACScoreChanges
#CytRx $CYTR BidaskScore is Downgraded to Held
June 18th 2018, 6:06pm
ConsumerFeed @ConsumerFeed
CytRx Co. $CYTR Expected to Announce Earnings of -$0.18 Per Share https://t.co/Gjzg8iWosx
June 17th 2018, 11:06am
809trader @809trader
$CYTR just added 7k shares :) she is getting ready
June 12th 2018, 1:06pm
dakotafinancial @dakotafinancial
CytRx $CYTR Given a $5.00 Price Target by HC Wainwright Analysts https://t.co/C3IeDeQxwJ
June 9th 2018, 5:06am
ZolmaxNews @ZolmaxNews
CytRx $CYTR Given a $5.00 Price Target by HC Wainwright Analysts https://t.co/ie5yQTIqZE
June 9th 2018, 5:06am
Analyze4dollars @Analyze4dollars
$CYTR shaping up to be a great gap fill candidate
June 8th 2018, 12:06pm
OlympiaReport @OlympiaReport
HC Wainwright Analysts Give CytRx $CYTR a $5.00 Price Target https://t.co/8t9IO0kMIM
June 8th 2018, 5:06am
Analyze4dollars @Analyze4dollars
As mentioned previously, I like $CYTR here. It may not fill the gap entirely but it does have a history of large j… https://t.co/wqVB3yZH1e
June 7th 2018, 7:06pm
TheMarketsDaily @TheMarketsDaily
Windtree Therapeutics $WINT and CytRx $CYTR Critical Comparison https://t.co/PoHdQH4VwN
June 7th 2018, 11:06am
Ultra_Calls @Ultra_Calls
$CYTR CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data Presented at the American Society of Clinical Oncology 2018
June 7th 2018, 9:06am
stockpi31563696 @stockpi31563696
$CYTR Thanks for the low price levels last two days ... Pay off for the swing trade will start any moment..
June 7th 2018, 8:06am
ConsumerFeed @ConsumerFeed
CytRx $CYTR Given a $5.00 Price Target by HC Wainwright Analysts https://t.co/EWIsBEFntO
June 7th 2018, 5:06am
midetimes @midetimes
CytRx $CYTR and Oncobiologics $ONS Head-To-Head Review https://t.co/oMpzN5R0ks #stocks
June 6th 2018, 5:06am
dailypoliticaln @dailypoliticaln
CytRx $CYTR and Oncobiologics $ONS Head-To-Head Review https://t.co/hfccmvciip
June 6th 2018, 5:06am
AmericanBanking @AmericanBanking
HC Wainwright Analysts Give CytRx $CYTR a $5.00 Price Target https://t.co/3cNh3Hh30Q #stocks
June 5th 2018, 10:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.